Diagnostics Pipeline: Cizzle Bio Introduces Test for Earlier Lung Cancer Detection
The CIZ1B biomarker blood-based assay has 95% sensitivity for detecting earliest stage of the cancer
Already a member? Log in here
Emerging Tests-dtet
Diagnostics Pipeline: Xella Health Launches Platform Focused on Women’s Medical Issues
The startup is trying to close the care gap between female and male patients
Already a member? Log in here
Growing Need for Companion Diagnostics is Evident at Drug Discovery Event
The momentum for targeted therapies has downstream implications for clinical laboratories
Already a member? Log in here
Easy & Rapid Testing Remains Unavailable to Most Physicians
...
Already a member? Log in here
Serology Testing Critical to COVID-19 Survival & Post-Crisis Transition
...
Already a member? Log in here
Are Rapid Immunodiagnostic Tests for COVID-19 Ready for Prime Time?
...
Already a member? Log in here
FDA Takes Unprecedented Measures to Promote Rapid Development of Coronavirus Diagnostic Tests
...
Already a member? Log in here
CMS Develops Additional Code for Coronavirus Lab Tests
...
Already a member? Log in here
Top of the News: CMS Issues New Guidance for Laboratories Performing Coronavirus Testing
On Feb. 4, the Food and Drug Administration (FDA) granted emergency use authorization (EUA) clearance for the first test approved in the US for detecting the novel coronavirus. Developed by the US Centers for Disease Control and Prevention (CDC) using sequencing...
FDA Watch: Agency Grants Emergency Clearance for CDC Novel Coronavirus Detection Test
...
Already a member? Log in here
Standard Pathology Tests Outperform Molecular Subtyping in Bladder Cancer Tumor Classification
...
Already a member? Log in here
Zika Antibody Detection Tests Go from Emergency to Commercial Clearance
...
Already a member? Log in here